Skip to main content

Find Clinical Trials

Home
Conditions
Secondary Hyperparathyroidism

Clinical trial condition

Secondary Hyperparathyroidism

Explore clinical trials studying Secondary Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

99 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Secondary Hyperparathyroidism trial results

Completed

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1

NCT05832931

Conditions: Chronic Disease, Disease Attributes, End-Stage Kidney Disease (ESKD), +16 more
Locations: Site Number: USA016-1 Pine Bluff, Arkansas, United States

Site Number: USA032-1 Anaheim, California, United States

Site Number: USA031-1 Beverly Hills, California, United States

Site Number: USA020-1 Fairfield, California, United States

View all 68 locations

View Trial Details

Completed

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

NCT01167309

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: CRS Clinical Research Services Kiel GmbH Kiel, Germany

Centralny Szpital Kliniczny MON Warsaw, Poland

View Trial Details

Completed

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

NCT02133404

Conditions: Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations: Chugoku, Japan

Chūbu, Japan

Kanto, Japan

Kyushu, Japan

View Trial Details

Completed

Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients

NCT03937349

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Saint-Petersburg State University, Clinic of advanced medical technologies n.a. N.I.Pirogov Saint Petersburg, Russia

View Trial Details

Completed

Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism

NCT06187480

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +3 more
Locations: Mersin University Faculty of Medicine Mersin, Turkey (Türkiye)

View Trial Details

Completed

Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

NCT05540795

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +3 more
Locations: FifthSunYetSen Zhuhai, Guangzhou, China

View Trial Details

Completed

A Trial of SHR6508 in Secondary Hyperparathyroidism

NCT05221008

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Completed

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

NCT00999037

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations: UCLA Los Angeles, California, United States

View Trial Details

Completed

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

NCT04750460

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Saint-Petersburg State University Hospital Saint Petersburg, Russia

View Trial Details

Completed

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

NCT00345839

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations: Not specified

View Trial Details